You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API TELAVANCIN HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing TELAVANCIN HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Theravance Inc	VIBATIV	telavancin hydrochloride	52118-001	HYDROXYPROPYLBETADEX	2027-01-01
Theravance Inc	VIBATIV	telavancin hydrochloride	52118-001	MANNITOL	2027-01-01
Cumberland Pharmaceuticals Inc	VIBATIV	telavancin hydrochloride	66220-315	HYDROCHLORIC ACID	2027-01-01
Cumberland Pharmaceuticals Inc	VIBATIV	telavancin hydrochloride	66220-315	HYDROXYPROPYL BETADEX	2027-01-01
Cumberland Pharmaceuticals Inc	VIBATIV	telavancin hydrochloride	66220-315	MANNITOL	2027-01-01
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for TELAVANCIN HYDROCHLORIDE

Excipient focus: HYDROCHLORIC ACID

TELAVANCIN HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Cumberland Pharmaceuticals Inc	telavancin hydrochloride	66220-315
>Company	>Ingredient	>NDC

TELAVANCIN HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Theravance Inc	telavancin hydrochloride	52118-001
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL BETADEX

TELAVANCIN HYDROCHLORIDE drug variants containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Cumberland Pharmaceuticals Inc	telavancin hydrochloride	66220-315
>Company	>Ingredient	>NDC

TELAVANCIN HYDROCHLORIDE drug variants not containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Theravance Inc	telavancin hydrochloride	52118-001
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYLBETADEX

TELAVANCIN HYDROCHLORIDE drug variants containing HYDROXYPROPYLBETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Theravance Inc	telavancin hydrochloride	52118-001
>Company	>Ingredient	>NDC

TELAVANCIN HYDROCHLORIDE drug variants not containing HYDROXYPROPYLBETADEX

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Cumberland Pharmaceuticals Inc	telavancin hydrochloride	66220-315
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

TELAVANCIN HYDROCHLORIDE drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Theravance Inc	telavancin hydrochloride	52118-001
Cumberland Pharmaceuticals Inc	telavancin hydrochloride	66220-315
>Company	>Ingredient	>NDC

TELAVANCIN HYDROCHLORIDE drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

TELAVANCIN HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Cumberland Pharmaceuticals Inc	telavancin hydrochloride	66220-315
>Company	>Ingredient	>NDC

TELAVANCIN HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Theravance Inc	telavancin hydrochloride	52118-001
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.